Article Versions Notes

Mohammed OA, Abdel-Reheim MA, Saleh LA, Alamri MMS, Alfaifi J, Adam MIE, Farrag AA, AlQahtani AAJ, BinAfif WF, Hashish AA, et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals. 2023; 16(8):1123. https://doi.org/10.3390/ph16081123

Mohammed, Osama A., Mustafa Ahmed Abdel-Reheim, Lobna A. Saleh, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I. E. Adam, Alshaimaa A. Farrag, AbdulElah Al Jarallah AlQahtani, Waad Fuad BinAfif, Abdullah A. Hashish, and et al. 2023. "Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach" Pharmaceuticals 16, no. 8: 1123. https://doi.org/10.3390/ph16081123

Mohammed, O. A., Abdel-Reheim, M. A., Saleh, L. A., Alamri, M. M. S., Alfaifi, J., Adam, M. I. E., Farrag, A. A., AlQahtani, A. A. J., BinAfif, W. F., Hashish, A. A., Abdel-Ghany, S., Elmorsy, E. A., El-wakeel, H. S., Doghish, A. S., Hamad, R. S., & Saber, S. (2023). Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals, 16(8), 1123. https://doi.org/10.3390/ph16081123